A Narrative Review of Weight Management Strategies: From Lifestyle Interventions to Emerging Pharmacotherapies.

IF 4.1 Q2 ENDOCRINOLOGY & METABOLISM
Iman Saad Ahmed, Sara Luay Tapponi, Hala Malek Manaa, Amina Soltani, Elzahraa Shehata Hussein, Fatemeh Ali Parvaresh, Zahid Hussain
{"title":"A Narrative Review of Weight Management Strategies: From Lifestyle Interventions to Emerging Pharmacotherapies.","authors":"Iman Saad Ahmed, Sara Luay Tapponi, Hala Malek Manaa, Amina Soltani, Elzahraa Shehata Hussein, Fatemeh Ali Parvaresh, Zahid Hussain","doi":"10.1155/jobe/6556057","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Obesity is a chronic, multifactorial disease associated with significant cardiometabolic, psychological, and socioeconomic consequences. Its complex etiology necessitates integrated, evidence-based management strategies beyond simple caloric restriction.</p><p><strong>Objective: </strong>This narrative review aims to critically evaluate current and emerging weight management strategies, including lifestyle interventions, dietary patterns, behavioral approaches, pharmacotherapy, and bariatric procedures, with attention to efficacy, limitations, sustainability, and real-world applicability.</p><p><strong>Methods: </strong>A structured literature search was conducted using PubMed, Scopus, ScienceDirect, and Google Scholar to identify relevant peer-reviewed articles on obesity management. Studies addressing dietary strategies, physical activity, behavioral therapy, antiobesity medications, and surgical or endoscopic interventions were included. Evidence was synthesized narratively, emphasizing comparative effectiveness, safety considerations, and long-term challenges.</p><p><strong>Results: </strong>Lifestyle interventions remain the foundation of obesity management; however, long-term success is often limited by physiological adaptations, behavioral factors, and socioeconomic barriers. Among dietary approaches, differences in weight loss tend to diminish over time, highlighting adherence and sustainability as key determinants of success. Pharmacotherapy has advanced significantly, particularly with incretin-based agents such as GLP-1 receptor agonists and dual GIP/GLP-1 agonists, which produce substantial weight loss and cardiometabolic benefits but require ongoing use and may be limited by cost and tolerability. Bariatric surgery remains the most effective long-term intervention for severe obesity, while less invasive endoscopic procedures are expanding treatment options. Behavioral and psychological support plays a critical role in improving adherence across all interventions.</p><p><strong>Conclusion: </strong>Effective obesity management requires a personalized, multidisciplinary approach integrating sustainable lifestyle strategies with pharmacological or procedural therapies when appropriate. While recent therapeutic innovations have expanded treatment possibilities, long-term success depends on behavioral support, accessibility, and continued evaluation of safety and cost-effectiveness.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":"2026 1","pages":"e6556057"},"PeriodicalIF":4.1000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13075284/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Obesity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/jobe/6556057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Obesity is a chronic, multifactorial disease associated with significant cardiometabolic, psychological, and socioeconomic consequences. Its complex etiology necessitates integrated, evidence-based management strategies beyond simple caloric restriction.

Objective: This narrative review aims to critically evaluate current and emerging weight management strategies, including lifestyle interventions, dietary patterns, behavioral approaches, pharmacotherapy, and bariatric procedures, with attention to efficacy, limitations, sustainability, and real-world applicability.

Methods: A structured literature search was conducted using PubMed, Scopus, ScienceDirect, and Google Scholar to identify relevant peer-reviewed articles on obesity management. Studies addressing dietary strategies, physical activity, behavioral therapy, antiobesity medications, and surgical or endoscopic interventions were included. Evidence was synthesized narratively, emphasizing comparative effectiveness, safety considerations, and long-term challenges.

Results: Lifestyle interventions remain the foundation of obesity management; however, long-term success is often limited by physiological adaptations, behavioral factors, and socioeconomic barriers. Among dietary approaches, differences in weight loss tend to diminish over time, highlighting adherence and sustainability as key determinants of success. Pharmacotherapy has advanced significantly, particularly with incretin-based agents such as GLP-1 receptor agonists and dual GIP/GLP-1 agonists, which produce substantial weight loss and cardiometabolic benefits but require ongoing use and may be limited by cost and tolerability. Bariatric surgery remains the most effective long-term intervention for severe obesity, while less invasive endoscopic procedures are expanding treatment options. Behavioral and psychological support plays a critical role in improving adherence across all interventions.

Conclusion: Effective obesity management requires a personalized, multidisciplinary approach integrating sustainable lifestyle strategies with pharmacological or procedural therapies when appropriate. While recent therapeutic innovations have expanded treatment possibilities, long-term success depends on behavioral support, accessibility, and continued evaluation of safety and cost-effectiveness.

体重管理策略的叙述性回顾:从生活方式干预到新兴药物治疗。
背景:肥胖是一种慢性、多因素疾病,与显著的心脏代谢、心理和社会经济后果相关。其复杂的病因需要综合的、基于证据的管理策略,而不仅仅是简单的热量限制。目的:这篇叙述性综述旨在批判性地评估当前和新兴的体重管理策略,包括生活方式干预、饮食模式、行为方法、药物治疗和减肥程序,并关注疗效、局限性、可持续性和现实世界的适用性。方法:使用PubMed、Scopus、ScienceDirect和b谷歌Scholar进行结构化文献检索,找出与肥胖管理相关的同行评议文章。研究包括饮食策略、体育活动、行为治疗、抗肥胖药物以及手术或内窥镜干预。证据综合叙述,强调比较有效性,安全性考虑和长期挑战。结果:生活方式干预仍然是肥胖管理的基础;然而,长期成功往往受到生理适应、行为因素和社会经济障碍的限制。在饮食方法中,减肥的差异往往会随着时间的推移而缩小,强调坚持和可持续性是成功的关键决定因素。药物治疗已经取得了显著进展,特别是以肠促胰岛素为基础的药物,如GLP-1受体激动剂和双重GIP/GLP-1激动剂,它们可以产生显著的体重减轻和心脏代谢益处,但需要持续使用,并且可能受到成本和耐受性的限制。减肥手术仍然是治疗严重肥胖的最有效的长期干预手段,而侵入性较小的内窥镜手术正在扩大治疗选择。行为和心理支持在提高所有干预措施的依从性方面发挥着关键作用。结论:有效的肥胖管理需要个性化的、多学科的方法,将可持续的生活方式策略与适当的药物或程序治疗相结合。虽然最近的治疗创新扩大了治疗的可能性,但长期的成功取决于行为支持、可及性以及对安全性和成本效益的持续评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Obesity
Journal of Obesity ENDOCRINOLOGY & METABOLISM-
CiteScore
7.50
自引率
3.00%
发文量
19
审稿时长
21 weeks
期刊介绍: Journal of Obesity is a peer-reviewed, Open Access journal that provides a multidisciplinary forum for basic and clinical research as well as applied studies in the areas of adipocyte biology & physiology, lipid metabolism, metabolic syndrome, diabetes, paediatric obesity, genetics, behavioural epidemiology, nutrition & eating disorders, exercise & human physiology, weight control and health risks associated with obesity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书